Literature DB >> 9177276

Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.

Z Zhang1, Y Zhao, Y Batres, M F Lin, S Y Ying.   

Abstract

Activin A, a homodimer of the betaA subunit of inhibin, is a member of the TGF-beta family. It is a multifunctional molecule regulating the growth, differentiation, and survival of a variety of cells. Treatment with activin A to an androgen-sensitive human prostatic cancer cell line LNCaP resulted in growth and morphological change and those were accompanied by up-regulation of prostatic differentiation markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP). In addition, the expression of androgen receptor was also enhanced by activin treatment. These results suggest that activin has significant influence on LNCaP cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177276     DOI: 10.1006/bbrc.1997.6649

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Authors:  Barbara H Jung; Stayce E Beck; Jennifer Cabral; Eddy Chau; Betty L Cabrera; Antonio Fiorino; E Julieta Smith; Melanie Bocanegra; John M Carethers
Journal:  Gastroenterology       Date:  2006-11-16       Impact factor: 22.682

2.  Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma.

Authors:  Christopher W Seder; Wibisono Hartojo; Lin Lin; Amy L Silvers; Zhuwen Wang; Dafydd G Thomas; Thomas J Giordano; Guoan Chen; Andrew C Chang; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

Review 3.  New insights into ovarian function.

Authors:  Joanne S Richards; Stephanie A Pangas
Journal:  Handb Exp Pharmacol       Date:  2010

4.  Overexpression of activin A in stage IV colorectal cancer.

Authors:  S Wildi; J Kleeff; H Maruyama; C A Maurer; M W Büchler; M Korc
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

5.  Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study).

Authors:  Linda T Roten; Matthew P Johnson; Siri Forsmo; Elizabeth Fitzpatrick; Thomas D Dyer; Shaun P Brennecke; John Blangero; Eric K Moses; Rigmor Austgulen
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

6.  Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.

Authors:  Ingrid Babel; Rodrigo Barderas; Ramón Díaz-Uriarte; Jorge Luis Martínez-Torrecuadrada; Marta Sánchez-Carbayo; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2009-07-28       Impact factor: 5.911

7.  Activin receptor signaling regulates prostatic epithelial cell adhesion and viability.

Authors:  Derek P Simon; Sivan Vadakkadath Meethal; Andrea C Wilson; Miguel J Gallego; Stephanie L Weinecke; Erin Bruce; Patrick F Lyons; Ryan J Haasl; Richard L Bowen; Craig S Atwood
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

8.  Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer.

Authors:  H Kaneda; T Arao; K Matsumoto; M A De Velasco; D Tamura; K Aomatsu; K Kudo; K Sakai; T Nagai; Y Fujita; K Tanaka; K Yanagihara; Y Yamada; I Okamoto; K Nakagawa; K Nishio
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

9.  Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.

Authors:  R H van Schaik; C D Wierikx; M A Timmerman; M H Oomen; W M van Weerden; T H van der Kwast; G J van Steenbrugge; F H de Jong
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

10.  Change in the Gastro-Intestinal Tract by Overexpressed Activin Beta A.

Authors:  Mi-Nyeu Kim; Young Il Kim; Chunghee Cho; Kelly E Mayo; Byung-Nam Cho
Journal:  Mol Cells       Date:  2015-11-24       Impact factor: 5.034

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.